hydroxychloroquine has been researched along with Dermatomycoses in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Dermatomycoses: Superficial infections of the skin or its appendages by any of various fungi.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of primary cutaneous cryptococcosis in a patient taking adalimumab, methotrexate, and hydroxychloroquine for rheumatoid arthritis." | 7.74 | Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab. ( Mowad, CM; Sewell, LD; Wilson, ML, 2008) |
| " We present a 52-year-old woman with a history of amyopathic dermatomyositis complicated by interstitial lung disease managed with mycophenolate mofetil and hydroxychloroquine who presented with a 7-month history of recurrent subcutaneous nodules as well as intermittent diarrhea and chronic sinusitis." | 3.96 | Cutaneous microsporidiosis in an immunosuppressed patient. ( Bradt, AR; Fullen, DR; Goldsmith, CS; Nadelman, DA; Qvarnstrom, Y; Smith, EH; Wang, F; Zaki, SR, 2020) |
| " We report a case of primary cutaneous cryptococcosis in a patient taking adalimumab, methotrexate, and hydroxychloroquine for rheumatoid arthritis." | 3.74 | Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab. ( Mowad, CM; Sewell, LD; Wilson, ML, 2008) |
| "Mucormycosis is an invasive fungal infection (IFI) due to several species of saprophytic fungi, occurring in patients with underlying co-morbidities (including organ transplantation)." | 1.62 | Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature. ( Berlinrut, I; Chang, KM; Khatri, A; Wallach, F, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Nadelman, DA | 1 |
| Bradt, AR | 1 |
| Qvarnstrom, Y | 1 |
| Goldsmith, CS | 1 |
| Zaki, SR | 1 |
| Wang, F | 1 |
| Smith, EH | 1 |
| Fullen, DR | 1 |
| Khatri, A | 1 |
| Chang, KM | 1 |
| Berlinrut, I | 1 |
| Wallach, F | 1 |
| Wilson, ML | 1 |
| Sewell, LD | 1 |
| Mowad, CM | 1 |
3 other studies available for hydroxychloroquine and Dermatomycoses
| Article | Year |
|---|---|
Cutaneous microsporidiosis in an immunosuppressed patient.
Topics: Dermatomycoses; Dermatomyositis; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Immunocompro | 2020 |
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature.
Topics: Aged; Anti-Infective Agents; Bacteremia; Catheter-Related Infections; Coinfection; Combined Modality | 2021 |
Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antirheuma | 2008 |